Member Info for crumbs

Yeah HP

1 million cups of coffee a day drank on picket lines 20 million biscuits eaten

:))))

I think it was Ray who said the other day

The T Cells have not stopped working ...

Patience required

Could be better than that Juno $9 billion Kite $12 billion ... As pharma wanted in on CAR T techs ... very expensive techs with many issues no clear patent owners of that therapeutic class and up to now commercially doing about $1.7 billion in sales I think on possibly 3 approved products for I think a few blood cancer targets....

Moditope is a whole new class of therapeutic... cheap to make and easy to administer... with so far no toxicity issues.... then there are the targets and amounts of potential patients..... could well call this a class of its own... able to create its own market and who has all the patents for any pharma wanting in on this whole new class... oh that would be scancell :)

I think its more to do with ripping the parcels away from the letters and dumping letters on the GOV

Thanks, Ruck :) ... Notice I put Tuesday for all the RNSs
reckon £8 will be where the golden dust bowl of crosses forms and might retrace a little there 7.90s... and BB will be full of doom but once past that..... whoosh

But mentioning Nobel prizes I reckon Lindy will have one before this decade ends

First, we smash a quid then it's up to 2 pretty soon after that 3 then onto 4........ this is how it will go with RNSs every Tuesday right up to 80 quids when Lindy will bring Pfizer Merck and Roche in-house :)

The root of the rot comes down from the top... I fear for old twitchy-eyes Thompson that fungus is eating his face up

A lot of potential newsflows... intriguing about potential deals on the MaB use in CAR T... they are talking to potential partners there too... Covidity news coming meaning a clinical satge deal ready Avidimab -partnership talks there too ... but of course, the number one is if modi 1 is doing the business and we are getting regular updates on strong indicative data.... and mainstream media coverage begins then I think that alone has with no deals even attached the potential of getting the sp to a quid.... best case scenario that though and there are other less best case ones lol

Lindy already said BioNtech will likely get involved on modi 1 proving itself and she said there are others.... we know Genentech/Roche has a heads up via Mellman... but really if modi 1 does what it could and may well already be doing then every single pharma involved in oncology will be calling

'It's a massive question also involving the amount of cash Scancell will have to expend to get the product to a saleable point.'

The Modify trial will prove the science of modi 1 or otherwise .... so that money is already spent...Then I presume it will likely be target-by-target deals so what is that... up to 15 or more targets...

Tens of £billions

'The fact remains that account was brand new, had no other post history, is not a member of any groups on that site.. and only questioned the scancell patient. So I stand behind my assessment.'

That's my suspicions confirmed then..... Case closed

We don't know do we and I can't be bothered to check on that poster's history or possible lack of to determine ...We all hope patient 1 continues to have a positive life-improving response to what is likely (not certain till biopsies) immune response to modi 1 dosing same as all the other trial participants that are weekly growing in numbers... scancell do seem to have the plan to get the news out once they can be sure... so tickets bought and a comfy seat found the rest is down to time and news releases

Instead of a Friday night Fight night, we can have a Sunday Roast :) ... anyways certainly is plenty to talk about apart from patient 1 and an sp that has found 20p again, at last, makes it all more fun:) ... This being scancell there will be twists and turns but if modi 1 is indeed doing what we know it might do then all bets are off on just what may happen here and that I think would even be without a done deal on that platform ... the data and the media catch light to it the sp certainly won't lag behind

It seems someone on there is anxious about the sharing of the next scan results may well be genuine or may be a scancell investor wanting some gravy ....

Indeed if it's good news it will be coming out and possibly by patient 1 and others agreeing to mainstream media coverage... not for investors here to undermine the trial by trying to do what? gain some titbit by immoral means which in the context of the full trial means nothing... the data is what counts and that comes via RNS when it is actually seen that it is CD4 killers triggered by modi 1 infiltrating and destroying tumors that is when we get to know know... of course, these early signs of that indeed possibly happening is exciting but a little more patience required

The best practice IMHO is not to name known trial participants without them knowingly having their trial experience shared i.e if they appear on TV etc and not to direct quote anything they may share via a forum for disease sufferers and certainly absolutely never ever engage with patients on such forums unless you yourself have a legitimate reason to be on it and being a scancell investor is not one! ...Otherwise, that is sick morally bankrupt, and misses the whole concept of this is a trial and very early days one at that, such behavior makes you some kind of stalker...of course, sharing that there is publicly viewable information out there relating to the trial participants is not a crime but this trial is such that we will get to know the effectiveness or otherwise of modi 1 soon enough anyways no need to risk putting very ill people under any afdded stess

Mate it's not happening like their nonexistent shares rats you are going to have to let it go.... No more Friday Night Fight nights here :)))

(at least for now)) ...

I agree violin about RNS wording... we know how AIM loves an over reaction to badly worded ones:)
but hey by that RNS modi 1 initial news may be out big time who knows ... because unlike ImmunoBody which is something of a deal problem platform... moditope will sell itself and then some if its doing the magic